Drugs / aBM-MNC
aBM-MNC
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01374854 | Jan 2009 → Dec 2010 | type 1 diabetes mellitus | Fuzhou General Hospital | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | aBM-MNC | “autologous bone marrow mononuclear cell (aBM-MNC) stem cell transplantation (SCT)” PMID 35086778 ↗ Jan 2022 |
| Known as | autologous bone marrow mononuclear cell | “autologous bone marrow mononuclear cell (aBM-MNC) stem cell transplantation (SCT)” PMID 35086778 ↗ Jan 2022 |
| Known as | Umbilical mesenchymal stem cell (UC-MSCs) infusion | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01374854 ↗ |
| Route | Other | “106.8 × 10(6)/kg aBM-MNC through supraselective pancreatic artery cannulation” PMID 26628416 ↗ Dec 2015 |